182 related articles for article (PubMed ID: 16547692)
1. Intensified, intermittent, low-dose intravenous cyclophosphamide together with oral alternate-day steroid therapy in lupus nephritis (long-term outcome).
Calguneri M; Ozbalkan Z; Ozturk MA; Apras S; Ertenli AI; Kiraz S
Clin Rheumatol; 2006 Nov; 25(6):782-8. PubMed ID: 16547692
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive therapy in lupus nephritis.
D'Cruz D; Cuadrado MJ; Mujic F; Tungekar MF; Taub N; Lloyd M; Khamashta MA; Hughes GR
Clin Exp Rheumatol; 1997; 15(3):275-82. PubMed ID: 9177922
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children.
Tangnararatchakit K; Tapaneya-Olarn C; Tapaneya-Olarn W
J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S104-10. PubMed ID: 10730528
[TBL] [Abstract][Full Text] [Related]
4. Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial.
Gourley MF; Austin HA; Scott D; Yarboro CH; Vaughan EM; Muir J; Boumpas DT; Klippel JH; Balow JE; Steinberg AD
Ann Intern Med; 1996 Oct; 125(7):549-57. PubMed ID: 8815753
[TBL] [Abstract][Full Text] [Related]
5. Overwhelming septic cavernous sinus thrombosis in a woman after combination of high-dose steroid and intravenous cyclophosphamide therapy for lupus nephritis.
Chen YC; Cheng TT; Lai HM; Wu CH
Lupus; 2000; 9(1):78-9. PubMed ID: 10713653
[TBL] [Abstract][Full Text] [Related]
6. Long-term prognosis of diffuse lupus nephritis.
Ponticelli C; Zucchelli P; Moroni G; Cagnoli L; Banfi G; Pasquali S
Clin Nephrol; 1987 Dec; 28(6):263-71. PubMed ID: 3327639
[TBL] [Abstract][Full Text] [Related]
7. Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis.
Boumpas DT; Austin HA; Vaughn EM; Klippel JH; Steinberg AD; Yarboro CH; Balow JE
Lancet; 1992 Sep; 340(8822):741-5. PubMed ID: 1356175
[TBL] [Abstract][Full Text] [Related]
8. Short course of weekly low-dose intravenous pulse cyclophosphamide in the treatment of lupus nephritis: a preliminary study.
Houssiau FA; D'Cruz DP; Haga HJ; Hughes GR
Lupus; 1991 Nov; 1(1):31-5. PubMed ID: 1845361
[TBL] [Abstract][Full Text] [Related]
9. A controlled trial of pulse cyclophosphamide versus pulse methylprednisolone in severe lupus nephritis.
Sesso R; Monteiro M; Sato E; Kirsztajn G; Silva L; Ajzen H
Lupus; 1994 Apr; 3(2):107-12. PubMed ID: 7920609
[TBL] [Abstract][Full Text] [Related]
10. Intravenous pulse cyclophosphamide treatment of severe lupus nephritis: a prospective five-year study.
Valeri A; Radhakrishnan J; Estes D; D'Agati V; Kopelman R; Pernis A; Flis R; Pirani C; Appel GB
Clin Nephrol; 1994 Aug; 42(2):71-8. PubMed ID: 7955581
[TBL] [Abstract][Full Text] [Related]
11. Clinical effects of intermittent, intravenous cyclophosphamide in severe systemic lupus erythematosus.
Martinelli R; Pereira LJ; Santos ES; Rocha H
Nephron; 1996; 74(2):313-7. PubMed ID: 8893147
[TBL] [Abstract][Full Text] [Related]
12. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
Shen K; Yu Y; Tang Z; Liu Z; Li L
Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
[TBL] [Abstract][Full Text] [Related]
13. Long term efficacy of high-dose intravenous methylprednisolone pulses in active lupus nephritis. A 21-month prospective study.
Bertoni M; Brugnolo F; Bertoni E; Salvadori M; Romagnani S; Emmi L
Scand J Rheumatol; 1994; 23(2):82-6. PubMed ID: 8165443
[TBL] [Abstract][Full Text] [Related]
14. [Improvement of the maintenance therapy after methylprednisolone pulse therapy--effect of prednisolone combined with immunosuppressants].
Miyamae T; Nakasima S; Imagawa T; Ito S; Katakura S; Tomono N; Mori M; Ibe M; Mitsuda T; Aihara Y; Yokota S
Ryumachi; 1999 Dec; 39(6):829-35. PubMed ID: 10695406
[TBL] [Abstract][Full Text] [Related]
15. [A case of lupus nephritis resistant to steroid pulse therapy markedly improved by bolus intravenous cyclophosphamide therapy].
Moriuchi J; Ichikawa Y; Takaya M; Shimizu H; Kurata T; Arimori S
Ryumachi; 1989 Aug; 29(4):291-6. PubMed ID: 2617371
[TBL] [Abstract][Full Text] [Related]
16. Treatment of membranous lupus nephritis with nephrotic syndrome by sequential immunosuppression.
Chan TM; Li FK; Hao WK; Chan KW; Lui SL; Tang S; Lai KN
Lupus; 1999; 8(7):545-51. PubMed ID: 10483033
[TBL] [Abstract][Full Text] [Related]
17. Treatment of proliferative lupus nephritis with methylprednisolone pulse therapy and oral azathioprine.
de Glas-Vos JW; Krediet RT; Weening JJ; Arisz L
Neth J Med; 1995 Jan; 46(1):4-14. PubMed ID: 7877712
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppressive treatment of the glomerulonephritis of systemic lupus.
Faedda R; Palomba D; Satta A; Pirisi M; Tanda F; Bartoli E
Clin Nephrol; 1995 Dec; 44(6):367-75. PubMed ID: 8719548
[TBL] [Abstract][Full Text] [Related]
19. [Cyclophosphamide therapy in systemic lupus erythematosus].
Backhaus M; Hiepe F
Z Rheumatol; 1997; 56(4):178-89. PubMed ID: 9417758
[TBL] [Abstract][Full Text] [Related]
20. [Effect of methylprednisolone pulse therapy in patients with lupus nephritis assessed by WHO morphologic classification].
Makino H; Yamasaki Y; Hayashi Y; Haramoto T; Shikata K; Kumagai I; Taniai K; Takahashi K; Ota Z
Nihon Jinzo Gakkai Shi; 1990 Jul; 32(7):791-9. PubMed ID: 2273595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
